At a glance | 2000 | 2011 | 2021 | 2030 | 2045 |
---|---|---|---|---|---|
Diabetes estimates (20-79 y) | |||||
People with diabetes, in 1,000s | 7,113.2 | 10,674.3 | 11,005.0 | 10,542.7 | 10,117.9 |
Age-adjusted comparative prevalence of diabetes, % | - | 7.7 | 6.6 | 7.7 | 8.3 |
People with undiagnosed diabetes, in 1,000s | - | - | 5,007.3 | - | - |
Proportion of people with undiagnosed diabetes, % | - | - | 45.5 | - | - |
Impaired glucose tolerance (IGT) estimates (20-79 y) | |||||
People with IGT, in 1,000s | - | 13,638.2 | 12,043.0 | 11,404.2 | 10,446.2 |
Age-adjusted comparative prevalence of IGT, % | - | 11.5 | 9.4 | 10.4 | 10.9 |
Impaired fasting glucose (IFG) estimates (20-79 y) | |||||
People with IFG, in 1,000s | - | - | 5,567.9 | 5,174.3 | 4,557.6 |
Age-adjusted comparative prevalence of IFG, % | - | - | 4.5 | 4.6 | 4.6 |
Mortality attributable to diabetes (20-79 y) | |||||
Deaths attributable to diabetes | - | 81,446.0 | 245,010.0 | - | - |
Proportion of diabetes-related deaths in people under 60 y, % | - | - | 1.4 | - | - |
Type 1 diabetes estimates in children and adolescents | |||||
New cases of type 1 diabetes (0-14 y), in 1,000s | 0.4 | 0.0 | 0.3 | - | - |
New cases of type 1 diabetes (0-19 y), in 1,000s | - | - | 0.5 | - | - |
Type 1 diabetes (0-14 y), in 1,000s | 2.8 | - | 2.2 | - | - |
Type 1 diabetes (0-19 y), in 1,000s | - | - | 4.5 | - | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | |||||
Live births affected by HIP | - | - | 49,642.4 | - | - |
Prevalence of gestational diabetes mellitus (GDM), % | - | - | 4.3 | - | - |
Live births affected by other types of diabetes first detected in pregnancy | - | - | 1,538.6 | - | - |
Live births affected by other types of diabetes detected prior to pregnancy | - | - | 1,843.0 | - | - |
Diabetes-related health expenditure | |||||
Total diabetes-related health expenditure, USD million | - | - | 35,648.5 | 32,889.7 | 29,427.4 |
Total diabetes-related health expenditure, ID million | - | - | 37,629.5 | 34,717.4 | 31,062.7 |
Diabetes-related health expenditure per person, USD | - | 3,266.0 | 3,239.3 | 2,988.6 | 2,674.0 |
Diabetes-related health expenditure per person, ID | - | - | 3,419.3 | 3,154.7 | 2,822.6 |
Demographics | |||||
Total adult population (20-79 y), in 1,000s | 95,849.0 | 95,340.6 | 93,187.4 | 86,423.8 | 76,932.9 |
Population of children (0-14 y), in 1,000s | 21,880.0 | - | 15,502.8 | - | - |
Population of children and adolescents (0-19 y), in 1,000s | - | - | 21,173.8 | - | - |
Complications of diabetes | |||||
Microvascular |
| ||||
Macrovascular |
|